查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1702369

全球球囊瓣膜成形術器械市場 - 2025 年至 2033 年

Global Balloon Valvuloplasty Devices Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 165 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球氣球瓣膜成形術設備市場規模達到 20.3 億美元，預計到 2033 年將達到 39.5 億美元，在 2025-2033 年預測期內的複合年成長率為 6.8%。

球囊瓣膜成形術裝置是用於治療瓣膜狹窄（心臟瓣膜變窄）的醫療設備。它們可以擴大瓣膜開口、改善血液流動並減輕症狀。它們通常用於介入性心臟病學，以緩解症狀、縮短恢復時間並減少住院時間。

市場動態：

駕駛員和約束裝置

心臟瓣膜疾病盛行率上升

全球球囊瓣膜成形術設備市場受到心臟瓣膜疾病盛行率不斷上升的推動，例如主動脈瓣狹窄、二尖瓣狹窄和肺動脈瓣疾病。人口老化和高血壓、糖尿病、肥胖和吸煙等生活方式相關的風險因素進一步加劇了這些狀況。球囊瓣膜成形術是外科瓣膜置換術的一種微創替代方法，具有住院時間短、恢復時間快、術後併發症少等優點。

例如，全球心血管疾病－心臟瓣膜疾病在全球呈現上升趨勢，其中最常見的是風濕性心臟病，影響4,100萬人，在發展中國家的發病率不斷上升。這是由於年輕成年人口的成長以及抗生素、微生物檢測和超音波心動圖技術的普及，從而降低了過早死亡率。

再狹窄和手術併發症的風險

全球球囊瓣膜成形術設備市場因再狹窄和其他手術併發症而面臨挑戰。再狹窄，即手術後治療瓣膜再次變窄，通常需要重複干預，對患者和醫療保健系統造成負擔。這在老年患者或鈣化嚴重的患者中尤其明顯，因為這種手術的效果可能是暫時的。

其他風險包括血管併發症、栓塞、心律不整和瓣膜逆流，導致患者預後不良。由於可能出現併發症，醫療保健提供者不願廣泛採用該手術，尤其是在有更耐用的替代方案（如手術瓣膜置換）可用的情況下。經導管主動脈瓣置換術（TAVR）等替代治療方案的可用性也可能限制球囊瓣膜成形術設備市場的成長。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第2章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按產品類型分類的程式碼片段
  • 按應用程式截取的程式碼片段
  • 按年齡分類
  • 最終用戶的程式碼片段
  • 按地區分類

第3章：動態

  • 影響因素
    • 驅動程式
      • 心臟瓣膜疾病盛行率上升
      • 科技進步的崛起
    • 限制
      • 再狹窄和手術併發症的風險
      • 設備成本高
    • 機會
      • 新興市場的擴張
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第5章：依產品類型

  • 標準氣球
  • 切割氣球
  • 得分氣球
  • 高壓氣球
  • 低壓氣球

第6章：按應用

  • 主動脈瓣狹窄
  • 肺動脈瓣狹窄

第7章：依年齡層

  • 兒科
  • 成人

第 8 章：按最終用戶

  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他

第9章：區域市場分析與成長機會

  • 北美洲
    • 關鍵區域特定動態
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 關鍵區域特定動態
      • 德國
      • 英國
      • 法國
      • 西班牙
      • 義大利
      • 歐洲其他地區
  • 拉丁美洲
    • 關鍵區域特定動態
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地區
  • 亞太
    • 關鍵區域特定動態
      • 中國
      • 印度
      • 日本
      • 韓國
      • 亞太其他地區
  • 中東和非洲
    • 關鍵區域特定動態

第10章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第 11 章：公司簡介

  • Medtronic
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 併購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT分析
  • Balton
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Cardinal Health, Inc
  • Cook Medical Inc
  • Terumo Corporation
  • Becton, Dickinson and Company (BD)
  • TORAY MEDICAL CO,. LTD.
  • BVM Medical

第 12 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章：附錄

簡介目錄
Product Code: MD9460

The global balloon valvuloplasty devices market reached US$ 2.03 billion in 2024 and is expected to reach US$ 3.95 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033.

Balloon valvuloplasty devices are medical devices used to treat valvular stenosis, a narrowing of heart valves. They widen the valve opening, improve blood flow, and reduce symptoms. They're commonly used in interventional cardiology for symptom relief, shorter recovery times, and reduced hospitalization duration.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Valvular Heart Diseases

The global balloon valvuloplasty devices market is driven by the increasing prevalence of valvular heart diseases, such as aortic stenosis, mitral stenosis, and pulmonary valve disorders. The aging population and lifestyle-related risk factors like hypertension, diabetes, obesity, and smoking further exacerbate these conditions. Balloon valvuloplasty is a minimally invasive alternative to surgical valve replacement, offering benefits like shorter hospital stays, faster recovery times, and reduced post-operative complications.

For instance, valvular heart disease, a global cardiovascular disease, is increasing globally, with rheumatic heart disease, the most common, affecting 41 million people, increasing in developing nations. This is due to the growth of the young adult population and improved access to antibiotics, microbiological testing, and echocardiography, which have reduced premature mortality rates.

Risk of Restenosis and Procedural Complications

The global balloon valvuloplasty devices market faces challenges due to restenosis and other procedural complications. Restenosis, the re-narrowing of the treated valve after the procedure, often requires repeat interventions, burdening patients and healthcare systems. This is particularly evident in elderly patients or those with severe calcification, where the procedure's effectiveness may be temporary.

Other risks include vascular complications, embolization, arrhythmias, and valve regurgitation, leading to adverse patient outcomes. The potential for complications makes healthcare providers hesitant to adopt the procedure widely, especially when more durable alternatives like surgical valve replacement are available. The availability of alternative treatment options, such as transcatheter aortic valve replacement (TAVR), may also limit the growth of the balloon valvuloplasty devices market.

Segment Analysis

The global balloon valvuloplasty devices market is segmented based on product type, application, age group, end user, and region.

Product Type:

The standard balloon from product type segment is expected to dominate the balloon valvuloplasty devices market with the highest market share

Standard balloons are medical devices used in balloon valvuloplasty to dilate narrowed heart valves, restoring blood flow in patients with valvular stenosis. These high-strength balloons, available in various sizes and diameters, are delivered via catheter-based systems and inflated to break calcific deposits, improving valve function in high-risk patients not candidates for open-heart surgery.

The balloon valvuloplasty devices market is growing due to the increasing prevalence of valvular heart diseases, preference for minimally invasive procedures, technological advancements, expanding healthcare infrastructure, and government initiatives. Benefits include reduced hospital stays, faster recovery times, and fewer post-operative complications. Technological advancements and improved access to interventional cardiology in developing regions further support market growth.

Geographical Analysis

North America is expected to hold a significant position in the balloon valvuloplasty devices market with the highest market share

The North American balloon valvuloplasty devices market is growing due to the increasing prevalence of valvular heart diseases, especially among the aging population. Technological advancements and favorable reimbursement policies are driving innovation. Increased awareness among healthcare professionals and patients, coupled with rising healthcare expenditure and government support for cardiovascular disease management, is expected to further accelerate market growth in North America.

For instance, in January 2025, Concept Medical has enrolled the first patient in its MAGICAL trial, comparing its sirolimus-coated balloon to traditional angioplasty for patients with below-the-knee PDA. The company secured an Investigational Device Exemption from the FDA for the MagicTouch PTA and is launching two more trials to evaluate its drug-coated alternative.

Competitive Landscape

The major global players in the balloon valvuloplasty devices market include Medtronic, Balton, Boston Scientific Corporation, B. Braun Melsungen AG, Cardinal Health, Inc., Cook Medical Inc., Terumo Corporation, Becton, Dickinson and Company (BD), TORAY MEDICAL CO,.LTD., and BVM Medical, among others.

Key Developments

  • In February 2025, Cagent Vascular launched the Serranator SL-PRO percutaneous transluminal angioplasty (PTA) serration balloon catheter for chronic limb-threatening ischaemia and pedal disease. The catheter uses Cagent's proven serration technology on a redesigned platform, offering improved deliverability and trackability. It also offers 1,000 times increase in point force compared to plain balloons and a controlled lumen gain with minimal dissection.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global balloon valvuloplasty devices market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by Age Group
  • 2.6. Snippet by End User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Valvular Heart Diseases
      • 3.1.1.2. Rise in the Technological Advancements
    • 3.1.2. Restraints
      • 3.1.2.1. Risk of Restenosis and Procedural Complications
      • 3.1.2.2. High Cost of Devices
    • 3.1.3. Opportunity
      • 3.1.3.1. Expansion in Emerging Markets
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Standard Balloon*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Cutting Balloon
  • 5.4. Scoring Balloon
  • 5.5. High-Pressure Balloon
  • 5.6. Low-Pressure Balloon

6. By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Aortic Valve Stenosis*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Pulmonary Valve Stenosis

7. By Age Group

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 7.1.2. Market Attractiveness Index, By Age Group
  • 7.2. Pediatric*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Adult

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Specialty Clinics
  • 8.5. Others

9. Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of Latin America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Medtronic*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Balton
  • 11.3. Boston Scientific Corporation
  • 11.4. B. Braun Melsungen AG
  • 11.5. Cardinal Health, Inc
  • 11.6. Cook Medical Inc
  • 11.7. Terumo Corporation
  • 11.8. Becton, Dickinson and Company (BD)
  • 11.9. TORAY MEDICAL CO,. LTD.
  • 11.10. BVM Medical

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us